About Resmed
ResMed (ASX:RMD) is a health technology company focused on developing, manufacturing, and marketing medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, particularly sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. It is listed solely on the New York Stock Exchange under the symbol (NYSE:RMD). The company's projects aim to improve patients' quality of life, reduce the impact of chronic disease, and save healthcare costs globally. ResMed is dedicated to innovation and is continuously working on expanding its product line and improving its offerings through research and development. Its objectives include enhancing patient outcomes, expanding its global footprint, and leveraging technology to make healthcare more accessible and efficient.
Snapshot
Operations
Produtos e/ou serviços de Resmed
- Continuous Positive Airway Pressure (CPAP) devices for treating sleep apnea.
- Portable ventilators for patients with respiratory disorders.
- Sleep tracking and analysis technology to monitor sleep patterns and quality.
- Cloud-based software solutions for patient management and data analysis.
- Non-invasive ventilators supporting patients with chronic respiratory diseases.
- Oxygen therapy products, including concentrators and portable oxygen solutions.
equipe executiva do Resmed
- Mr. Michael J. Farrell BE, MBA, SMCEO & Chairman
- Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Non-Executive Director
- Mr. Brett A. SandercockChief Financial Officer
- Mr. Michael J. RiderChief Legal Officer & Secretary
- Mr. Justin LeongChief Product Officer
- Mr. Alastair RobertsonChief Information Officer
- Ms. Sallilyn SchwartzChief Investor Relations Officer
- Mr. Jim EllisChief Compliance Officer
- Ms. Yvonne-Katrin PucknatChief Marketing Officer
- Ms. Vered KeisarChief People Officer